Effect of supervised training on FEV1 in cystic fibrosis: A randomised controlled trial

Journal of Cystic Fibrosis

Volumn 12, Issue 6, 2013, Pages 714-720

  Kriemler, Susi ^a,e   Kieser, Stephanie ^b   Junge, Sibylle ^c   Ballmann, Manfred ^c   Hebestreit, Alexandra ^b   Schindler, Christian ^a   Stüssi, Christoph ^d   Hebestreit, Helge ^b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d Kantonsspital Muensterlingen   (Switzerland)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Exercise capacity; Lung function; Physical activity; Pulmonary rehabilitation

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY COMPOSITION; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; ENDURANCE TRAINING; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MALE; PHYSICAL ACTIVITY; PREDICTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REGISTER; RESISTANCE TRAINING; TRAINING;

AEROBIC TRAINING; AT; CF; CON(CH); CON(D); CONTROL GROUP GERMANY; CONTROL GROUP SWITZERLAND; CYSTIC FIBROSIS; EXERCISE CAPACITY; FEV(1); FORCED EXPIRATORY VOLUME IN ONE SECOND; FORCED VITAL CAPACITY; FVC; LUNG FUNCTION; MAXIMAL OXYGEN CONSUMPTION AT PEAK ENDURANCE; MAXIMAL WATT PERFORMANCE; PHYSICAL ACTIVITY; PULMONARY REHABILITATION; RESIDUAL VOLUME OVER TOTAL LUNG CAPACITY; RV/TLC; ST; STRENGTH TRAINING; VIGOROUS PHYSICAL ACTIVITY; VO2(PEAK); VPA; W(MAX);

ADULT; CYSTIC FIBROSIS; EXERCISE THERAPY; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; PHYSICAL ENDURANCE; QUALITY OF LIFE; RESISTANCE TRAINING; VITAL CAPACITY; YOUNG ADULT;

EID: 84888039747     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2013.03.003     Document Type: Article

References (27)

1. Boyle M.P. Adult cystic fibrosis. JAMA 2007, 298(15):1787-1793.
2. Schneiderman-Walker J., Pollock S.L., Corey M., Wilkes D.D., Canny G.J., Pedder L., et al. A randomized controlled trial of a 3-year home exercise program in cystic fibrosis. J Pediatr 2000, 136(3):304-310.
3. Hebestreit H., Kieser S., Junge S., Ballmann M., Hebestreit A., Schindler C., et al. Long-term effects of a partially supervised conditioning programme in cystic fibrosis. Eur Respir J 2010, 35(3):578-583.
4. Klijn P.H., Oudshoorn A., van der Ent C.K., van der Net J., Kimpen J.L., Helders P.J. Effects of anaerobic training in children with cystic fibrosis: a randomized controlled study. Chest 2004, 125(4):1299-1305.
5. Moorcroft A.J., Dodd M.E., Morris J., Webb A.K. Individualised unsupervised exercise training in adults with cystic fibrosis: a 1year randomised controlled trial. Thorax 2004, 59(12):1074-1080.
6. Selvadurai H.C., Blimkie C.J., Meyers N., Mellis C.M., Cooper P.J., Van Asperen P.P. Randomized controlled study of in-hospital exercise training programs in children with cystic fibrosis. Pediatr Pulmonol 2002, 33(3):194-200.
7. Bradley J., Moran F. Physical training for cystic fibrosis. Cochrane Database Syst Rev 2008, 1:CD002768.
8. Sherrill D.L., Lebowitz M.D., Knudson R.J., Burrows B. Continuous longitudinal regression equations for pulmonary function measures. Eur Respir J 1992, 5(4):452-462.
9. Schoni-Affolter F., Oswald P., Wandt-Baumann C., Kriemler S., Schoni M.H. Schweiz Med Wochenschr 2000, 130(39):1373-1381. [Schweizerisches Register fur Patienten mit zystischer Fibrose: Planung, Programmierung, Ausfuhrung und erste Beispiele der Anwendung].
10. Stern M., Sens B., Wiedemann B., Busse O., Wenzlaff P. Qualitätssicherung Mukoviszidose. Überblick über den Gesundheitszustand der Patienten in Deutschland 2001 2002, Zentrum für Qualitätsmanagement im Gesundheitswesen, Hannover, Germany.
11. Slaughter M.H., Lohman T.G., Boileau R.A., Horswill C.A., Stillman R.J., Van Loan M.D., et al. Skinfold equations for estimation of body fatness in children and youth. Hum Biol 1988, 60(5):709-723.
12. Durnin J.V., Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72years. Br J Nutr 1974, 32(1):77-97.
13. Inbar O., Bar-Or O., Skinner J.S. The Wingate Anaerobic Test 1996, Human Kinetics, Champaign, IL.
14. Godfrey S. Exercise testing in children: applications in health and disease 1974, W.B. Saunders Co. Ltd., London.
15. Freedson P., Pober D., Janz K.F. Calibration of accelerometer output for children. Med Sci Sports Exerc 2005, 37(11 Suppl.):S523-S530.
16. Matthew C.E. Calibration of accelerometer output for adults. Med Sci Sports Exerc 2005, 37(11 Suppl.):S512-S522.
17. Hayllar K.M., Williams S.G., Wise A.E., Pouria S., Lombard M., Hodson M.E., et al. A prognostic model for the prediction of survival in cystic fibrosis. Thorax 1997, 52(4):313-317.
18. Nixon P.A., Orenstein D.M., Kelsey S.F., Doershuk C.F. The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med 1992, 327(25):1785-1788.
19. Belkin R.A., Henig N.R., Singer L.G., Chaparro C., Rubenstein R.C., Xie S.X., et al. Risk factors for death of patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med 2006, 173(6):659-666.
20. Ruf K., Winkler B., Hebestreit A., Gruber W., Hebestreit H. Risks associated with exercise testing and sports participation in cystic fibrosis. J Cyst Fibros 2010, 9(5):339-345.
21. McIlwaine M. Chest physical therapy, breathing techniques and exercise in children with CF. Paediatr Respir Rev 2007, 8(1):8-16.
22. Hebestreit A., Kersting U., Basler B., Jeschke R., Hebestreit H. Exercise inhibits epithelial sodium channels in patients with cystic fibrosis. Am J Respir Crit Care Med 2001, 164(3):443-446.
23. Tirakitsoontorn P., Nussbaum E., Moser C., Hill M., Cooper D.M. Fitness, acute exercise, and anabolic and catabolic mediators in cystic fibrosis. Am J Respir Crit Care Med 2001, 164(8 Pt. 1):1432-1437.
24. Timmons B.W., Tarnopolsky M.A., Snider D.P., Bar-Or O. Immunological changes in response to exercise: influence of age, puberty, and gender. Med Sci Sports Exerc 2006, 38(2):293-304.
25. Cooper D.M. Exercise and cystic fibrosis: the search for a therapeutic optimum. Pediatr Pulmonol 1998, 25(3):143-144.
26. de Meer K., Jeneson J.A., Gulmans V.A., van der Laag J., Berger R. Efficiency of oxidative work performance of skeletal muscle in patients with cystic fibrosis. Thorax 1995, 50(9):980-983.
27. Schibler A., Bolt I., Gallati S., Schoni M.H., Kraemer R. High morbidity and mortality in cystic fibrosis patients compound heterozygous for 3905insT and deltaF508. Eur Respir J 2001, 17(6):1181-1186.